LYEL · Lyell Immunopharma, Inc. · Documents
$9.31
-0.08 (-0.85%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$228.14M
Shares
24.51M
Volume · Oct 26
85.22K
Avg daily vol (3M)
152.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-10-24 | — | |
| 10-Q | — | 2024-08-07 | 2024-06-30 | |
| 8-K | — | 2024-08-07 | — | |
| 8-K | — | 2024-06-26 | — | |
| 8-K | — | 2024-06-14 | — | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| 8-K | — | 2024-05-06 | — | |
| ARS | — | 2024-04-22 | 2023-12-31 | |
| DEFA14A | — | 2024-04-22 | — | |
| DEF 14A | — | 2024-04-22 | 2023-06-14 | |
| S-3 | — | 2024-02-29 | — | |
| 8-K | — | 2024-02-28 | — | |
| 10-K | — | 2024-02-28 | 2023-12-31 | |
| 8-K | — | 2023-11-20 | 2023-11-16 | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-11-07 | — | |
| 8-K | — | 2023-09-11 | — | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-06-21 | 2023-06-16 | |
| 8-K | — | 2023-06-06 | 2023-06-01 | |
| 8-K | — | 2023-05-04 | — | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| ARS | — | 2023-04-28 | 2022-12-31 | |
| DEF 14A | — | 2023-04-27 | — | |
| DEFA14A | — | 2023-04-27 | — | |
| 10-K | — | 2023-02-28 | 2022-12-31 | |
| 8-K | — | 2023-02-28 | — | |
| 8-K | — | 2022-12-16 | 2022-12-14 | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-08 | — | |
| 8-K | — | 2022-10-24 | — | |
| 8-K | — | 2022-10-06 | — | |
| 8-K | — | 2022-08-04 | — | |
| S-3ASR | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-06-13 | 2022-06-08 | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-08 | |
| 10-K | — | 2022-03-29 | 2021-12-31 | |
| 8-K | — | 2022-03-29 | — | |
| 8-K | — | 2022-02-15 | 2022-02-11 | |
| 8-K | — | 2021-12-17 | 2021-12-15 | |
| 8-K | — | 2021-12-03 | 2021-12-02 | |
| 8-K | — | 2021-11-12 | — | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| 8-K | — | 2021-10-28 | 2021-10-23 | |
| 8-K/A | — | 2021-10-01 | 2021-09-29 | |
| 8-K | — | 2021-09-30 | 2021-09-29 |
Showing 51–100 of 104 filings
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
12 filings
12 filers
Visit website
Investor relations